Peripheral Drug Eluting Stent System
- UID
- MFG/MD/2020/000086_45c357483978f9bc5cdb225296076384_bf4eb6f36306e39c5388994b7c275e0a
- Device class
- Class D
- Brand name
- TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM
- License holder
- Relisys Medical Devices Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- The Peripheral Drug-eluting Stent System is indicated for improving luminal diameter in the treatment of de novo or restenotic symptomatic lesion(TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM) in native vascular disease of the above-the-knee femoropopliteal arteries with reference vessel diameter from 4.0 mm to 6.5 mm
Peripheral Drug Eluting Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000086_45c357483978f9bc5cdb225296076384_bf4eb6f36306e39c5388994b7c275e0a. This device is marketed under the brand name TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM. The license holder is Relisys Medical Devices Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.